Archer Foundation
- Assets
- $1.6m
- Revenue
- $109.7k
- Investments
- $906.4k
- Employees
- 0
- Location
- Las Vegas, NV
- Founding
- 08/2012
- Data as of
- 12/2021
- EIN
- 45-4008807
Organization Overview
Archer Foundation is located in Las Vegas, NV. The organization was established in 2012. According to its NTEE Classification (T20) the organization is classified as: Private Grantmaking Foundations, under the broad grouping of Philanthropy, Voluntarism & Grantmaking Foundations and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Archer Foundation is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2021, Archer Foundation generated $109.7k in total revenue. This represents relatively stable growth, over the past 7 years the organization has increased revenue by an average of 1.8% each year. All expenses for the organization totaled $264.7k during the year ending 12/2021. While expenses have increased by 6.2% per year over the past 7 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Since 2015, Archer Foundation has awarded 17 individual grants totaling $1,430,000. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990PF
Mission & Program ActivityExcerpts From the 990PF Filing
TAX YEAR
2021
Describe the Organization's Program Activity:
Part 3 - Line 4a
IN 2020, THE ORGANIZATION MADE CONTRIBUTIONS TO YALE UNIVERSITY TO ADVANCE UNDERSTANDING OF NEURODEGENERATION FOCUSED ON DEVELOPING NOVEL PET TRACERS TO PROVIDE A NONINVASIVE,RELIABLE, AND SENSITIVE METHOD FOR QUANTIFYING SYNAPTIC LOSS IN THE EARLY DETECTION OF ALZHEIMER'S DISEASE.
IN 2020, THE ORGANIZATION MADE CONTRIBUTIONS TO WASHINGTON UNIVERSITY TO ADVANCE UNDERSTANDING OF NEUROSCIENCES WITH A PARTICULAR FOCUS ON ROLE OF FLUID-BASED BIOMARKERS TO AID IN THE STUDY OF ALZHEIMER DISEASE.
IN 2020, THE ORGANZATION MADE CONTRIBUTIONS TO STANFORD UNIVERSITY RESEARCH MANAGEMENT GROUP TO SUPPORT THE RESEARCH OF MIRO, AN EARLY MOLECULAR MEASURMENT FOR PARKINSON'S DISEASE.
IN 2020, THE ORGANZATION MADE CONTRIBUTIONS TO REGENTS OF THE UNIVERSITY OF CALIFORNIA TO SUPPORT THE RESEARCH OF VASCULAR-INDUCED ASTROCYTIC SIGNALING IN NEURODEGENERATIVE DISEASE.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Betty L Van Steenwyk Trustee, President | 5 | $0 | |
Matthew D Van Steenwyk Trustee, Treasurer | 5 | $0 | |
Elizabeth Busby Trustee, Secretary | 0 | $0 | |
Matthew T Van Steenwyk Trustee | 0 | $0 | |
Gretchen C Van Steenwyk Trustee | 0 | $0 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Contributions, Gifts, Grants & Similar | $0 |
| Interest on Savings | $3 |
| Dividends & Interest | $31,923 |
| Net Rental Income | $0 |
| Net Gain on Sale of Assets | $71,801 |
| Capital Gain Net Income | $71,801 |
| Net ST Capital Gain | $0 |
| Income Modifications | $0 |
| Profit on Inventory Sales | $0 |
| Other Income | $6,006 |
| Total Revenue | $109,733 |
| Statement of Expenses | |
|---|---|
| Compensation of officers, directors, trustees, etc | $0 |
| Other employee salaries and wages | $0 |
| Pension plans, employee benefits | $0 |
| Interest | $2 |
| Taxes | $686 |
| Depreciation | $0 |
| Occupancy | $0 |
| Travel, conferences, and meetings | $0 |
| Printing and publications | $0 |
| Other expenses | $7,077 |
| Total operating and administrative expenses | $64,708 |
| Contributions, gifts, grants paid | $200,000 |
| Total expenses and disbursements | $264,708 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $61,503 |
| Savings and temporary cash investments | $583,461 |
| Net Accounts receivable | $0 |
| Net Pledges Receivable | $0 |
| Grants receivable | $0 |
| Receivables from Officers, Directors, or Controlling Persons | $0 |
| Net other notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $0 |
| Net Investments - land, buildings, equipment | $0 |
| Investments—mortgage loans | $0 |
| Investments—other | $75,998 |
| Net Land, buildings, and equipment | $0 |
| Other assets | $0 |
| Total assets | $1,551,351 |
| Accounts payable and accrued expenses | $0 |
| Grants payable | $0 |
| Deferred revenue | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Mortgages and other notes payable | $0 |
| Other liabilities | $0 |
| Total liabilities | $0 |
Grants Awarded
Over the last fiscal year, Archer Foundation has awarded $200,000 in support to 3 organizations.
| Grant Recipient | Amount |
|---|---|
STANFORD UNIVERSITY RESEARCH MANAGEMENT GROUP PURPOSE: TO SUPPORT THE RESEARCH OF MIRO, AN EARLY MOLECULAR MEASURMENT FOR PARKINSON'S DISEASE. | $25,000 |
WASHINGTON UNIVERSITY PURPOSE: TO ADVANCE UNDERSTANDING OF NEUROSCIENCES WITH A PARTICULAR FOCUS ON ROLE OF FLUID-BASED BIOMARKERS TO AID IN THE STUDY OF ALZHEIMER DISEASE. | $100,000 |
YALE UNIVERSITY PURPOSE: TO ADVANCE UNDERSTANDING OF NEURODEGENERATION FOCUSED ON DEVELOPING NOVEL PET TRACERS TO PROVIDE A NONINVASIVE, RELIABLE, AND SENSITIVE METHOD FOR QUANTIFYING SYNAPTIC LOSS IN THE EARLY DETECTION OF ALZHEIMER'S DISEASE. | $75,000 |